tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Matthew Taylor, 183 are a BUY (60.6%), 94 are a HOLD (31.13%), 25 are a SELL (8.28%).
Analyst Matthew Taylor, currently employed at JEFFERIES, carries an average stock price target met ratio of 63.9% that have a potential upside of 20.31% achieved within 191 days. Previously, Matthew Taylor worked at UBS.
Matthew Taylor’s has documented 606 price targets and ratings displayed on 39 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PODD, Insulet at 12-Oct-2026.
Analyst best performing recommendations are on TNDM (TANDEM DIABETES CARE).
The best stock recommendation documented was for TNDM (TANDEM DIABETES CARE) at 11/27/2018. The price target of $36 was fulfilled within 2 days with a profit of $2.71 (8.14%) receiving and performance score of 40.7.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Jun-2017
$120
$16.3 (15.72%)
$112
Buy Since 05-Jun-2019
$122
$18.3 (17.65%)
$112
Buy Since 22-Oct-2018
$118
$14.3 (13.79%)
$120
Buy Since 01-Jun-2021
$125
$21.3 (20.54%)
$134
Buy Since 22-Jan-2017
$118
$14.3 (13.79%)
$135
Which stock is Matthew Taylor most bullish on?
Which stock is Matthew Taylor most reserved on?
What Year was the first public recommendation made by Matthew Taylor?
